These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7083769)

  • 21. A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
    Bowman SL; Hudson SA; Simpson G; Munro JF; Clements JA
    Br J Clin Pharmacol; 1986 May; 21(5):529-32. PubMed ID: 3718810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease.
    Crabtree JE; Heatley RV; Losowsky MS
    Gut; 1989 Oct; 30(10):1339-43. PubMed ID: 2583562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malabsorption of dietary folate (Pteroylpolyglutamates) in adult coeliac disease and dermatitis herpetiformis.
    Hoffbrand AV; Douglas AP; Fry L; Stewart JS
    Br Med J; 1970 Oct; 4(5727):85-9. PubMed ID: 5471775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study by perfusion techniques of the absorption abnormalities in the jejunum in adult coeliac disease.
    Russell RI; Allan JG; Gerskowitch VP; Robertson JW
    Clin Sci; 1972 Jun; 42(6):735-41. PubMed ID: 5033809
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological determinants of propranolol disposition in man.
    Kornhauser DM; Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1978 Feb; 23(2):165-74. PubMed ID: 620476
    [No Abstract]   [Full Text] [Related]  

  • 28. Absorption of inorganic and haemoglobin iron in coeliac disease.
    Anand BS; Callender ST; Warner GT
    Br J Haematol; 1977 Nov; 37(3):409-14. PubMed ID: 603771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrogenic glucose absorption in untreated and treated coeliac disease.
    Read NW; Levin RJ; Holdsworth CD
    Gut; 1976 Jun; 17(6):444-9. PubMed ID: 955501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal absorption of propranolol from different dosage forms by rats and dogs.
    Hussain A; Hirai S; Bawarshi R
    J Pharm Sci; 1980 Dec; 69(12):1411-3. PubMed ID: 7463327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unstirred layer and kinetics of electrogenic glucose absorption in the human jejunum in situ.
    Read NW; Barber DC; Levin RJ; Holdsworth CD
    Gut; 1977 Nov; 18(11):865-76. PubMed ID: 590846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
    Wells PG; Feely J; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioavailability of propranolol: twice-daily versus four times-daily administration.
    Dvornik D; Kraml M; Dubuc J; Patterson-Kreuscher S; Milosovich G; Mullane JF
    J Clin Pharmacol; 1981; 21(11):472-6. PubMed ID: 7334139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
    Wagner JG
    Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA synthesis by jejunal mucosa in responsive and non-responsive coeliac disease.
    Jones PE; Peters TJ
    Br Med J; 1977 Apr; 1(6069):1130-1. PubMed ID: 861498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisolone absorption in coeliac disease.
    Pickup ME; Farah F; Lowe JR; Dixon JS; Record CO
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):87-9. PubMed ID: 488136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective synthesis of apolipoprotein A-I in jejunal mucosa in coeliac disease.
    Florén CH; Alm P
    Scand J Gastroenterol; 1988 Sep; 23(7):856-60. PubMed ID: 3067329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an elemental diet (Vivonex) on the absorption abnormalities and histological appearances of the jejunum in untreated adult coeliac disease.
    Russell RI; Atherton ST; Nelson LM; Robertson E; Lee FD
    Digestion; 1979; 19(5):335-9. PubMed ID: 488554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man.
    Cid E; Mella F; Lucchini L; Cárcamo M; Monasterio J
    Biopharm Drug Dispos; 1986; 7(6):559-66. PubMed ID: 3828485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.